Prevalence of antibodies against hepatitis B virus and hepatitis C virus among blood donors in Lebanon, 1997-2003

American Journal of Infection Control

Volumn 34, Issue 4, 2006, Pages 241-243

  Irani Hakime, Noha ^a   Musharrafieh, Umayya ^b   Samaha, Hanady ^a   Almawi, Wassim Y ^c  

^a St Georges University Hospital   (Lebanon)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LEBANON; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; SCREENING; VIRUS TRANSMISSION;

ADULT; BLOOD DONORS; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LEBANON; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 33646193746     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2005.06.009     Document Type: Article

References (12)

1. Kleinman S., Busch M.P., Korelitz J.J., and Schreiber G.B. The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfus Med Rev 11 (1997) 155-172
2. Anzola M. Hepatocellular carcinoma: role of hepatitis B and hepatitis C viruses proteins in hepatocarcinogenesis. J Viral Hepat 11 (2004) 383-390
3. Blakely T.A., Bates M.N., Baker M.G., and Tobias M. Hepatitis B carriage explains the excess rate of hepatocellular carcinoma for Maori, Pacific Island and Asian people compared to Europeans in New Zealand. Int J Epidemiol 28 (1999) 204-210
4. Wasley A., and Alter M.J. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20 (2000) 1-16
5. Naman R.E., Mansour I., Klayme S., and Khalil G. Hepatitis C virus in hemodialysis patients and blood donors in Lebanon. J Med Liban 44 (1996) 4-9
6. Irani-Hakime N., Tamim H., Samaha H., and Almawi W.Y. Prevalence of antibodies against hepatitis C virus among blood donors in Lebanon, 1997-2000. Clin Lab Haematol 23 (2001) 317-323
7. Nassar N.T., Alami S.Y., Nasrallah S.M., and Allam C.K. The prevalence of hepatitis B surface antigen (HBsAg) among students and blood donors at the American University of Beirut (AUB). Johns Hopkins Med J 139 Suppl (1976) S45-S48
8. Nabulsi M.M., El Saleeby C.M., Araj G.F., and Lebanese Hepatitis B Collaborative Study Group. The current status of hepatitis B in Lebanon. J Med Liban 51 (2003) 64-70
9. Takano S., Nakamura K., Kawai S., Yokosuka O., Satomura Y., and Omata M. Prospective assessment of donor blood screening for antibody to hepatitis C virus by first- and second-generation assays as a means of preventing posttransfusion hepatitis. Hepatology 23 (1996) 708-712
10. Beld M., Penning M., van Putten M., Lukashov V., van den Hoek A., McMorrow M., et al. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood. Hepatology 29 (1999) 1288-1298
11. Bizollon T., Ahmed S.N., Guichard S., Chevallier P., Adham M., Ducerf C., Baulieux J., and Trepo C. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients. Gut 47 (2000) 698-702
12. Burnouf T., and Radosevich M. Reducing the risk of infection from plasma products: specific preventative strategies. Blood Rev 14 (2000) 94-110